abstract |
The present invention pertains to: an agent for killing HIV-1-infected cells, the agent containing a compound shown by formula (I): (in the formula, Ar 1 and Ar 2 are the same or different, and are optionally substituted aromatic groups; X is -CH 2 O- or -CH=CH-), a salt thereof, or a solvate of these; and a combination formulation for simultaneous, separate, or sequential administration in the treatment or prevention of HIV-1 infection, wherein the combination formulation contains two separate formulations: (a) a formulation including a compound shown by formula (I), a salt thereof, or a solvate of these, and (b) a formulation including an anti-HIV-1 drug. |